Harvard-founded Nuvalent lured funding from Deerfield to debut with two assets devoted to overcoming kinase-driven resistance to non-small cell lung cancer.

The China Evergrande-backed mobility technology producer is joining forces with special purpose acquisition company Property Solutions Acquisition Corp.

SR One reinvested in a series B round for the degenerative disorder drug developer that was led by venture fund Logos Capital.

Stripe returned for a series C round that brought the back-office service provider's overall funding to over $118m and which will help expand its product offering.

BP Ventures, which led FreeWire's series A and B rounds, has returned for a series C round that pushed the EV charger provider's total funding to near $100m.

Princeton University has approved a six-figure commitment to the student-run Prospect Student Ventures launched last year.

Telstra Ventures co-led a round also backed by Qualcomm Ventures and Prologis Ventures, helping the logistics tracking technology provider reach $70m in total funding.

JPMorgan Chase and Mouro Capital helped the mortgage lending platform developer take its total funding to more than $65m.

The cancer drug developer's $12.8m seed round included Eli Lilly, and Lilly New Ventures' Brad Robling is a board observer.

Munich Re Ventures’ HSB Fund led a consortium for the fuse box technology developer's series B round that included Amazon's Alexa Fund.